Researchers have identified chemical compounds capable of priming host cells to fight diverse viral infections, marking a step toward broad-spectrum antivirals. In parallel, scientific understanding continues to map NETosis, an innate immune response where neutrophils detonate to trap and neutralize pathogens.
Broad-Spectrum Antiviral Compounds Screened from Thousands of Molecules
Scientists across multiple institutions have identified compounds that can fight off viral infection by activating a defense pathway inside host cells. Rather than targeting a single virus, these experimental compounds are designed to act as broad-spectrum therapeutics that could combat multiple viral strains.
The research team uncovered these candidates by screening nearly 400,000 commercially available and proprietary chemical molecules. Testing in human cells demonstrated that the compounds successfully fended off infections from respiratory syncytial virus (RSV), herpes virus, and Zika virus. The lead candidate also proved effective in combating herpes infection in a mouse model.
Optogenetics and the Integrated Stress Response Pathway
The newly identified compounds function by boosting the integrated stress response pathway within human cells. This cellular defense system naturally turns on during viral infections and other stresses like starvation. When viruses replicate, they produce double-stranded RNA, which triggers the pathway and shuts down protein synthesis to block viral reproduction.
To pinpoint molecules that enhance this defense, the research team invented a novel optogenetic screen. They engineered modifications into a protein called PKR, which turns on the stress pathway, inserting light-sensitive proteins into the cell genome so researchers could activate the response with blue light.
By applying library compounds to human cells alongside blue light simulation, researchers measured cell survival rates to identify which molecules amplified the cellular response. This high-throughput screen yielded roughly 3,500 candidate compounds showing potential antiviral activity.
“If the pathway were turned on in response to viral infection, what our compounds do is they turn it on full blast. Even in the presence of a small amount of virus, if the pathway is triggered, then the antiviral response is also maximized.”
Felix Wong, lead author of the paper and chief executive officer of Integrated Biosciences, via MIT News
From the thousands of initial hits, the team narrowed down their selection to eight promising compounds. After evaluating them for toxicity and virus-killing capability in human cells, the researchers selected three top candidates designated as IBX-200, IBX-202, and IBX-204.
Experiments revealed that these compounds activate an enzyme involved in detecting stress, priming cells to react more vigorously to viral invasion. When applied to uninfected cells, the compounds remain inert, causing no measurable effect.
Programmed Explosive Cell Death in Innate Immunity
While engineered compounds offer new ways to prime cellular defenses, the human body already utilizes radical mechanisms to neutralize invaders. A prominent example is NETosis, a programmed self-destructive response deployed by neutrophils, which are the most abundant white blood cells in human blood.
When neutrophils encounter certain classes of bacterial or fungal infections that resist phagocytosis, internal enzymes unwind cellular DNA, and the nuclear envelope breaks down. Chromatin expands, mixing with antimicrobial proteins stored in granules before bursting completely through the cell membrane.
This explosive action releases sticky webs of DNA and enzymes known as neutrophil extracellular traps, or NETs. These structures immobilize local pathogens and destroy them through direct chemical attack. The rapid version of this process can transpire in as little as five minutes, though the host neutrophil does not survive the detonation.
From 2004 Discovery to Recognized Immune Strategy
The specific mechanics of NETosis were first properly characterised in a 2004 paper in Science by Volker Brinkmann, Arturo Zychlinsky, and colleagues at the Max Planck Institute for Infection Biology in Berlin. Initially met with controversy because cell death contradicted standard assumptions about white blood cell function, the concept gained broader acceptance over the subsequent two decades.
Science now recognizes three distinct forms of NETosis: suicidal NETosis, the classical slow pathway destroying the cell entirely; vital NETosis, a faster pathway where neutrophils eject DNA via vesicular transport and briefly survive; and mitochondrial NETosis, which releases mitochondrial DNA instead of nuclear strands.
While the physical DNA webs are eventually degraded by bodily enzymes such as DNases and cleared by neighboring immune cells, the aftermath involves persistent chemical signals. Inflammatory cytokines and damage-associated molecular patterns linger in local tissue, triggering downstream immune activity long after the initial cellular explosion.
Related reading
